Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Mar;23(3):317–321. doi: 10.1111/j.1365-2125.1987.tb03051.x

The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam.

T Pullar, D Edwards, J R Haigh, S Peaker, M P Feely
PMCID: PMC1386230  PMID: 3567046

Abstract

The effect of cimetidine on the single dose pharmacokinetics of orally administered clobazam and N-desmethylclobazam (NDMC) was studied in volunteers. Cimetidine inhibited the elimination of both clobazam and NDMC and inhibited the rate of formation of NDMC from clobazam. The increase in the AUC for NDMC generated from clobazam was relatively greater than that for clobazam itself. This suggests that NDMC elimination is inhibited to a relatively greater extent than clobazam elimination. The increase in AUC for NDMC generated from clobazam was also relatively greater than that for NDMC administered orally. This would suggest that cimetidine either increases the bioavailability of clobazam or reduces that of NDMC. The increases in the AUC for NDMC and for clobazam in some individuals was of a magnitude which is likely to be clinically significant.

Full text

PDF
320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Desmond P. V., Patwardhan R. V., Schenker S., Speeg K. V., Jr Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med. 1980 Aug;93(2):266–268. doi: 10.7326/0003-4819-93-2-266. [DOI] [PubMed] [Google Scholar]
  2. Greenblatt D. J., Divoll M., Puri S. K., Ho I., Zinny M. A., Shader R. I. Clobazam kinetics in the elderly. Br J Clin Pharmacol. 1981 Nov;12(5):631–636. doi: 10.1111/j.1365-2125.1981.tb01281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Greene W. Drug interactions involving cimetidine--mechanisms, documentation, implications. Q Rev Drug Metab Drug Interact. 1984;5(1):25–51. doi: 10.1515/dmdi.1984.5.1.25. [DOI] [PubMed] [Google Scholar]
  4. Haigh J. R., Pullar T., Gent J. P., Dailley C., Feely M. N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? Br J Clin Pharmacol. 1987 Feb;23(2):213–218. doi: 10.1111/j.1365-2125.1987.tb03032.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jawad S., Richens A., Oxley J. Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. Br J Clin Pharmacol. 1984 Dec;18(6):873–877. doi: 10.1111/j.1365-2125.1984.tb02558.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klotz U., Arvela P., Rosenkranz B. Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam. Clin Pharmacol Ther. 1985 Dec;38(6):652–655. doi: 10.1038/clpt.1985.240. [DOI] [PubMed] [Google Scholar]
  7. Klotz U., Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med. 1980 May 1;302(18):1012–1014. doi: 10.1056/NEJM198005013021807. [DOI] [PubMed] [Google Scholar]
  8. Klotz U., Reimann I. Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam. Eur J Clin Pharmacol. 1980 Nov;18(6):517–520. doi: 10.1007/BF00874666. [DOI] [PubMed] [Google Scholar]
  9. McGowan W. A., Dundee J. W. The effect of intravenous cimetidine on the absorption of orally administered diazepam and lorazepam. Br J Clin Pharmacol. 1982 Aug;14(2):207–211. doi: 10.1111/j.1365-2125.1982.tb01963.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Patwardhan R. V., Yarborough G. W., Desmond P. V., Johnson R. F., Schenker S., Speeg K. V., Jr Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology. 1980 Nov;79(5 Pt 1):912–916. [PubMed] [Google Scholar]
  11. Ratnaraj N., Goldberg V., Lascelles P. T. Determination of clobazam and desmethylclobazam in serum using high-performance liquid chromatography. Analyst. 1984 Jul;109(7):813–815. doi: 10.1039/an9840900813. [DOI] [PubMed] [Google Scholar]
  12. Rupp W., Badian M., Christ O., Hajdú P., Kulkarni R. D., Taeuber K., Uihlein M., Bender R., Vanderbeke O. Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol. 1979;7 (Suppl 1):51S–57S. doi: 10.1111/j.1365-2125.1979.tb04665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Salonen M., Aantaa E., Aaltonen L., Kanto J. Importance of the interaction of midazolam and cimetidine. Acta Pharmacol Toxicol (Copenh) 1986 Feb;58(2):91–95. doi: 10.1111/j.1600-0773.1986.tb00076.x. [DOI] [PubMed] [Google Scholar]
  14. Tedeschi G., Riva R., Baruzzi A. Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients. Br J Clin Pharmacol. 1981 Jun;11(6):619–622. doi: 10.1111/j.1365-2125.1981.tb01180.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Volz M., Christ O., Kellner H. M., Kuch H., Fehlhaber H. W., Gantz D., Hajdu P., Cavagna F. Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol. 1979;7 (Suppl 1):41S–50S. doi: 10.1111/j.1365-2125.1979.tb04664.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES